Brief: Erytech Pharma SA- Expands Patent Portfolio For Treatment Of Rare Metabolic Diseases
08/02/2022 21:13
Feb 8 (Reuters) - Erytech Pharma SA ERYP.PA :
* ERYTECH PHARMA SA- EXPANDS PATENT PORTFOLIO FOR TREATMENT OF RARE
METABOLIC
DISEASES
Source text for Eikon: ID:nGNX4fL1d9
Further company coverage: ERYP.PA
Recent news on Phaxiam Therapeutics SA
See all newsBrief: Phaxiam Therapeutics Announces The Suspension Of Trading In Its Shares Until Delisting
Brief: Phaxiam Therapeutics Announces Judicial Liquidation And Delisting
Brief: Phaxiam Therapeutics Says Postponement Of The Offer Review Hearing
Brief: Phaxiam Therapeutics Announces Launch Of Process To Find Buyers In Context Of Its Receivership Procedure
Brief: Phaxiam Therapeutics Says Commercial Court Of Lyon To Open Judicial Receivership Procedure